PPD, Inc.

South Korea’s Ministry of Food and Drug Safety (MFDS) issued approvals for the conduct of 783 clinical trials over the course of 2023, up 10.1% from the previous year, led by an increase in work in on

One decade ago, when there was no viable innovative new drug R&D in China, a Chinese-American scientist and an American entrepreneur co-founded BeiGene, Ltd. . Now, BeiGene has grown to become a lea

In the more than six years since the US Food and Drug Administration approved Novartis AG ’s Kymriah (tisagenlecleucel) and Kite Pharma’s – now part of Gilead Sciences, Inc. – Yescarta (axicabtagen

The third-party vendors who manage Risk Evaluation and Mitigation Strategy (REMS) programs for drug sponsors mostly operate behind the scenes without public attention. But a provision inserted into th